{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:15:44Z","timestamp":1777598144382,"version":"3.51.4"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Acute myeloid leukemia (AML) is the common type of acute leukemia in adults. Definitive prognostic significance of variants of unknown significance lacks for many commonly mutated genes, including the isocitrate dehydrogenase 1 (IDH1) synonymous single nucleotide polymorphism (SNP) variant c.315C&amp;gt;T. In this retrospective cohort study of 248 AML patients at the University of Maryland Greenebaum Comprehensive Cancer Center, we show that the IDH1 c.315C&amp;gt;T SNP, previously reported to be associated with poor prognosis by other studies with conflicting data, does not confer worse prognosis, with a median overall survival (OS) of 17.1 months compared to 15.1 months for patients without this SNP (P=0.57). The lack of negative effect on prognosis by IDH1 SNP c.315C&amp;gt;T is consistent with the absence of amino acid alteration (p.Gly105Gly).<\/jats:p>","DOI":"10.3389\/fonc.2022.804961","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:42:27Z","timestamp":1647603747000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of IDH1 c.315C&gt;T SNP on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Elizabeth M.","family":"Corley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moaath K.","family":"Mustafa Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Alharthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A. F.","family":"Kline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie Y.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Niyongere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu H.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Emadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"B1","volume-title":"American Cancer Society: Cancer Facts and Figures\u00a02022","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0704-5","article-title":"Recent Drug Approvals for Newly Diagnosed Acute Myeloid Leukemia: Gifts or a Trojan Horse","volume":"34","author":"Estey","year":"2020","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0774-x","article-title":"Recent Drug Approvals for Acute Myeloid Leukemia","volume":"12","author":"Lai","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and Management of Acute Myeloid Leukemia in Adults: Recommendations From an International Expert Panel, on Behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1056\/nejmx130028","article-title":"Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia","volume":"369","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.435495","article-title":"The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization","volume":"288","author":"Ward","year":"2013","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.03.002","article-title":"Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acute Myeloid Leukemia","volume":"52","author":"Fathi","year":"2015","journal-title":"Semin Hematol"},{"key":"B8","unstructured":"COSMIC - Overview Cosm1741220"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.6899","article-title":"Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP Rs11554137 Is an Adverse Prognostic Factor","volume":"28","author":"Wagner","year":"2010","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-017-0852-6","article-title":"The Synonymous Isocitrate Dehydrogenase 1 315c>T SNP Confers an Adverse Prognosis in Egyptian Adult Patients With NPM1-\/CEBPA-Negative Acute Myeloid Leukemia","volume":"34","author":"Ali","year":"2018","journal-title":"Indian J Hematol Blood Transfusion"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348888","article-title":"Prognostic Implications of the IDH1 Synonymous SNP Rs11554137 in Pediatric and Adult AML: A Report From the Children\u2019s Oncology Group and SWOG","volume":"118","author":"Ho","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and Management of AML in Adults: 2017 ELN Recommendations From an International Expert Panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"B13","unstructured":"2021"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap Consortium: Building an International Community of Software Platform Partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inf"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)-A Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inf"},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1037\/a0019623","article-title":"Propensity Score Techniques and the Assessment of Measured Covariate Balance to Test Causal Associations in Psychological Research","volume":"15","author":"Harder","year":"2010","journal-title":"Psychol Methods"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Software"},{"key":"B18","volume-title":"WeightIt: Weighting for Covariate Balance in Observational Studies. R package version 0.9. 0","author":"Greifer","year":"2021"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.804961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T11:42:34Z","timestamp":1647603754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.804961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":18,"alternative-id":["10.3389\/fonc.2022.804961"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.804961","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"article-number":"804961"}}